Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP5354 for intraoperative ureter visualization in abdominopelvic surgery
NCT05999747Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2024
- Primary completion
- Oct 2025
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of pudexacianinium chloride, sponsored by Astellas Pharma. Started Mar 2024; status: completed.
02
Drugs
pudexacianinium chloride
Beyond the preview
Go deeper on NCT05999747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999747.